Alignment Healthcare Statistics
Total Valuation
ALHC has a market cap or net worth of $1.39 billion. The enterprise value is $1.26 billion.
| Market Cap | 1.39B |
| Enterprise Value | 1.26B |
Important Dates
The last earnings date was Thursday, May 2, 2024, after market close.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALHC has 191.20 million shares outstanding. The number of shares has increased by 3.22% in one year.
| Shares Outstanding | 191.20M |
| Shares Change (YoY) | +3.22% |
| Shares Change (QoQ) | +0.33% |
| Owned by Insiders (%) | 5.47% |
| Owned by Institutions (%) | 86.11% |
| Float | 102.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| Forward PS | 0.53 |
| PB Ratio | 10.59 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 1.30.
| Current Ratio | 1.57 |
| Quick Ratio | 1.41 |
| Debt / Equity | 1.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.27 |
Financial Efficiency
Return on equity (ROE) is -91.60% and return on invested capital (ROIC) is -45.04%.
| Return on Equity (ROE) | -91.60% |
| Return on Assets (ROA) | -22.60% |
| Return on Capital (ROIC) | -45.04% |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | -$102,379 |
| Employee Count | 1,536 |
| Asset Turnover | 2.90 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -23,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.99% in the last 52 weeks. The beta is 1.23, so ALHC's price volatility has been higher than the market average.
| Beta (1Y) | 1.23 |
| 52-Week Price Change | +5.99% |
| 50-Day Moving Average | 5.37 |
| 200-Day Moving Average | 6.50 |
| Relative Strength Index (RSI) | 79.05 |
| Average Volume (30 Days) | 1,024,422 |
Short Selling Information
The latest short interest is 5.99 million, so 3.13% of the outstanding shares have been sold short.
| Short Interest | 5.99M |
| Short Previous Month | 4.69M |
| Short % of Shares Out | 3.13% |
| Short % of Float | 5.84% |
| Short Ratio (days to cover) | 8.47 |
Income Statement
In the last 12 months, ALHC had revenue of $2.01 billion and -$157.25 million in losses. Loss per share was -$0.84.
| Revenue | 2.01B |
| Gross Profit | 213.57M |
| Operating Income | -135.76M |
| Pretax Income | -157.28M |
| Net Income | -157.25M |
| EBITDA | -110.85M |
| EBIT | -135.64M |
| Loss Per Share | -$0.84 |
Balance Sheet
The company has $301.71 million in cash and $170.47 million in debt, giving a net cash position of $131.24 million or $0.69 per share.
| Cash & Cash Equivalents | 301.71M |
| Total Debt | 170.47M |
| Net Cash | 131.24M |
| Net Cash Per Share | $0.69 |
| Equity / Book Value | 130.93M |
| Book Value Per Share | 0.68 |
| Working Capital | 189.90M |
Cash Flow
In the last 12 months, operating cash flow was -$150.54 million and capital expenditures -$39.83 million, giving a free cash flow of -$190.37 million.
| Operating Cash Flow | -150.54M |
| Capital Expenditures | -39.83M |
| Free Cash Flow | -190.37M |
| FCF Per Share | -$1.01 |
Margins
Gross margin is 10.61%, with operating and profit margins of -6.74% and -7.81%.
| Gross Margin | 10.61% |
| Operating Margin | -6.74% |
| Pretax Margin | -7.81% |
| Profit Margin | -7.81% |
| EBITDA Margin | -5.51% |
| EBIT Margin | -6.74% |
| FCF Margin | -9.46% |
Dividends & Yields
ALHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.22% |
| Shareholder Yield | -3.22% |
| Earnings Yield | -11.34% |
| FCF Yield | -13.73% |
Analyst Forecast
The average price target for ALHC is $8.69, which is 19.70% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.69 |
| Price Target Difference | 19.70% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 10.81% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALHC has an Altman Z-Score of 2.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.44 |
| Piotroski F-Score | 2 |